| __timestamp | Summit Therapeutics Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15635076 | 396000000 |
| Thursday, January 1, 2015 | 23943601 | 364000000 |
| Friday, January 1, 2016 | 23689111 | 376000000 |
| Sunday, January 1, 2017 | 41006114 | 382000000 |
| Monday, January 1, 2018 | 51379106 | 432000000 |
| Tuesday, January 1, 2019 | 32705593 | 457000000 |
| Wednesday, January 1, 2020 | 53274000 | 463000000 |
| Friday, January 1, 2021 | 85352000 | 508000000 |
| Saturday, January 1, 2022 | 51999000 | 539000000 |
| Sunday, January 1, 2023 | 59471000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Zoetis Inc. and Summit Therapeutics Inc. have demonstrated contrasting approaches to R&D investment. Zoetis, a leader in animal health, has consistently increased its R&D spending, peaking at approximately $614 million in 2023, a 55% rise from 2014. This robust investment underscores Zoetis's commitment to pioneering veterinary solutions.
Conversely, Summit Therapeutics, a clinical-stage biopharmaceutical company, has shown a more volatile R&D trajectory. Despite fluctuations, Summit's R&D expenses surged by 280% from 2014 to 2021, reflecting its aggressive pursuit of novel therapies. However, the subsequent decline suggests strategic recalibrations.
These trends highlight the dynamic nature of R&D strategies in the pharmaceutical sector, where companies balance innovation with financial prudence to drive future growth.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Zoetis Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Alnylam Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Summit Therapeutics Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.